Mark Christopher Capone insider trades

Open-market stock purchases and sales by Mark Christopher Capone, Director at Mesa Laboratories Inc /co/, from SEC Form 4 filings since Feb 18, 2010.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -11%.

Recent trades

DateStockTradeValue
Sep 9, 2026MLAB Mesa Laboratories Inc /co/Bought (not open market)—
Aug 15, 2026MLAB Mesa Laboratories Inc /co/Bought (not open market)—
Jul 10, 2026SERA Sera Prognostics, IncBought (not open market)—
Jul 10, 2026SERA Sera Prognostics, IncBought (not open market)—
Jul 10, 2026SERA Sera Prognostics, IncBought (not open market)—
Jul 10, 2026SERA Sera Prognostics, IncBought (not open market)—
Mar 10, 2026MLAB Mesa Laboratories Inc /co/Bought$99.3K

Companies traded

  • MLAB Mesa Laboratories Inc /co/: 1 buy, last Sep 9, 2026
  • SERA Sera Prognostics, Inc: other filings, last Jul 10, 2026
  • DMTK DermTech, Inc: other filings, last Jun 1, 2023
  • MYGN Myriad Genetics Inc: 1 buy, 24 sales, last Sep 30, 2019

Get free alerts when Mark Christopher Capone files a new trade →